Policlinico S. Orsola-Malpighi, Università di Bologna, Via Massarenti 9, 40138 Bologna, Italy
Arcispedale S. Anna-Cona, Università di Ferrara, Ferrara, Italy.
Europace. 2016 Oct;18(10):1551-1560. doi: 10.1093/europace/euw021. Epub 2016 Jun 14.
We investigated the applicability of the Ventricular Capture Control (VCC) and Atrial Capture Control (ACC) algorithms for automatic management of cardiac stimulation featured by Biotronik pacemakers in a broad, unselected population of pacemaker recipients.
Ventricular Capture Control and Atrial Capture Control were programmed to work at a maximum adapted output voltage as 4.8 V in consecutive recipients of Biotronik pacemakers. Ambulatory threshold measurements were made 1 and 12 months after pacemaker implant/replacement in all possible pacing/sensing configurations, and were compared with manual measurements. Among 542 patients aged 80 (73-85) years, 382 had a pacemaker implant and 160 a pacemaker replacement. Ventricular Capture Control could work at long term in 97% of patients irrespectively of pacing indication, lead type, and lead service life, performance being superior with discordant pacing/sensing configurations. Atrial Capture Control could work in 93% of patients at 4.8 V maximum adapted voltage and at any pulse width, regardless of pacing indication, lead type, and service life. At 12-month follow-up, a ventricular threshold increase ≥1.5 V had occurred in 4.4% of patients uneventfully owing to VCC functioning. Projected pacemaker longevity at 1 month was strongly correlated with the 12-month estimate, and exceeded 13 years in >60% of patients.
These algorithms for automatic management of pacing output ensure patient safety in the event of a huge increase of pacing threshold, while enabling maximization of battery longevity. Their applicability is quite broad in an unselected pacemaker population irrespectively of lead choice and service of life.
我们研究了心室感知控制(VCC)和心房感知控制(ACC)算法在 Biotronik 起搏器广泛的、未选择的起搏器受者人群中自动管理心脏刺激的适用性。
VCC 和 ACC 被编程为以 4.8V 的最大适应输出电压工作,在 Biotronik 起搏器的连续受者中。在所有可能的起搏/感知配置中,在起搏器植入/更换后 1 个月和 12 个月进行了动态阈值测量,并与手动测量进行了比较。在 542 名 80 岁(73-85 岁)的患者中,382 名植入了起搏器,160 名更换了起搏器。VCC 可以在 97%的患者中长期工作,与起搏指征、导联类型和导联使用寿命无关,其性能在不同步的起搏/感知配置中更优。在 4.8V 的最大适应电压和任何脉冲宽度下,ACC 可以在 93%的患者中工作,无论起搏指征、导联类型和使用寿命如何。在 12 个月的随访中,由于 VCC 的功能,4.4%的患者出现了 1.5V 以上的心室阈值增加,但无不良事件发生。预计 1 个月的起搏器寿命与 12 个月的估计值密切相关,超过 60%的患者超过 13 年。
这些用于自动管理起搏输出的算法在起搏阈值大幅增加的情况下确保了患者的安全,同时最大限度地延长了电池寿命。它们在未选择的起搏器人群中的适用性相当广泛,与导联选择和使用寿命无关。